BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 9, 2012
View Archived Issues
New antibody could facilitate early diagnosis of neurological disorders
Read More
Galectin Therapeutics prepares to advance lead candidate for NASH
Read More
DSMBs recommend continuation of ongoing RetinoStat and StarGen trials
Read More
NIH designs recombinant oncolytic immunotoxins that may be given at high doses
Read More
Investigation reveals new potential target for treating schizophrenia
Read More
Merck & Co. divulges novel candidate antihypertensives
Read More
Abbott presents new ALK inhibitors
Read More
U.S. university patents novel anticancer products
Read More
Adynxx completes enrollment in trial of lead pain therapeutic
Read More
Alimera Sciences to resubmit Iluvien NDA
Read More
Novel FFA2 receptor agonists reported by Galapagos
Read More
Ferrer files IND for topical antifungal agent
Read More
NICE guideline aims to improve outcome of lower limb peripheral arterial disease
Read More
Research at Merck & Co. yields new MR antagonists
Read More
NICE issues final guideline on assessing fragility fracture risk in adults
Read More
Novel bacterial OMV-based vaccines developed in U.S.
Read More
VitroGro CE mark approval application referred to U.K.'s MHRA
Read More
Ganitumab studies halted
Read More
New ROR1-binding antibodies designed in California
Read More
Recruitment complete in phase III OMS-103HP trial
Read More
Final data reported from phase II trial of nasal spray for binge eating disorder
Read More
Acetylon Pharmaceuticals begins phase Ib trials in multiple myeloma
Read More
Dicerna earns milestone payment in oncology collaboration
Read More
MJFF issues grant for potential rescue therapy for Parkinson's disease
Read More
SPA agreement reached for third phase III trial of oral laquinimod in RRMS
Read More
MEI Pharma enters agreement to acquire rights to oral HDAC inhibitor
Read More